TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TELO

Telomir Pharmaceuticals, Inc.

Healthcare · Biotechnology

1.10$ -0.9% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Telomir Pharmaceuticals, Inc. (TELO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.5% of the shares are freely tradable; institutional investors hold 3.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 3.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 35.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 66.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 69Mio.

Largest Shareholders

Institutions

Institutions TELO
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 1.45 995,373 +0.0 03/31/2026
BlackRock Inc 0.42 289,198 +1.3 03/31/2026
Geode Capital Management, LLC 0.36 249,086 +11.4 03/31/2026
Vanguard Fiduciary Trust Co 0.20 135,541 +0.0 03/31/2026
State Street Corp 0.09 58,600 +0.0 03/31/2026
Bank of New York Mellon Corp 0.07 51,454 +0.0 03/31/2026
Northern Trust Corp 0.06 41,844 +0.0 03/31/2026

Funds

Funds TELO
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.63 1,121,175 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.69 472,623 +0.0 07/31/2026
Fidelity Extended Market Index 0.31 210,401 -0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?